# Pharmacist Use of ECG to Inform Drug Therapy Decisions for Patients Receiving QT Prolonging Medications

> **NCT04000542** · NA · COMPLETED · sponsor: **Northeast Iowa Medical Education Foundation** · enrollment: 54 (actual)

## Conditions studied

- Torsades de Pointe Caused by Drug (Disorder)
- Torsades de Pointes
- Qt Interval, Variation in

## Interventions

- **OTHER:** Pharmacist Intervention

## Key facts

- **NCT ID:** NCT04000542
- **Lead sponsor:** Northeast Iowa Medical Education Foundation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-11
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04000542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04000542, "Pharmacist Use of ECG to Inform Drug Therapy Decisions for Patients Receiving QT Prolonging Medications". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04000542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
